Related references
Note: Only part of the references are listed.Lrp5 and bone formation A serotonin-dependent pathway
Vijay K. Yadav et al.
SKELETAL BIOLOGY AND MEDICINE (2010)
Genetic Analysis of Lrp5 Function in Osteoblast Progenitors
Vijay K. Yadav et al.
CALCIFIED TISSUE INTERNATIONAL (2010)
Low density lipoprotein receptor-related protein 5 (LRP5) mutations and osteoporosis, impaired glucose metabolism and hypercholesterolaemia
Anne Saarinen et al.
CLINICAL ENDOCRINOLOGY (2010)
Patients With High-Bone-Mass Phenotype Owing to Lrp5-T253I Mutation Have Low Plasma Levels of Serotonin
Morten Frost et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Osteocyte Wnt/β-Catenin Signaling Is Required for Normal Bone Homeostasis
Ina Kramer et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis
Vijay K. Yadav et al.
NATURE MEDICINE (2010)
Wnt signaling in development and disease
Jennifer L. Freese et al.
NEUROBIOLOGY OF DISEASE (2010)
Efficacy of Bisphosphonates in Reducing Fracture Risk in Postmenopausal Osteoporosis
John P. Bilezikian
AMERICAN JOURNAL OF MEDICINE (2009)
Genetic Control of Bone Formation
Gerard Karsenty et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2009)
The Expanded Biology of Serotonin
Miles Berger et al.
ANNUAL REVIEW OF MEDICINE (2009)
A Serotonin-Dependent Mechanism Explains the Leptin Regulation of Bone Mass, Appetite, and Energy Expenditure
Vijay K. Yadav et al.
CELL (2009)
Leptin Targets in the Mouse Brain
Michael M. Scott et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2009)
Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the Duodenum
Vijay K. Yadav et al.
CELL (2008)
Advances in male contraception
Stephanie T. Page et al.
ENDOCRINE REVIEWS (2008)
The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation
C. Collet et al.
FASEB JOURNAL (2008)
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Bisphosphonates: Mode of action and pharmacology
R. Graham G. Russell
PEDIATRICS (2007)
The serotonin signaling system: From basic understanding to drug development-for functional GI disorders
Michael D. Gershon et al.
GASTROENTEROLOGY (2007)
Wnt/β-catenin signaling in development and disease
Hans Clevers
CELL (2006)
Convergence between bone and energy homeostases: Leptin regulation of bone mass
Gerard Karsenty
CELL METABOLISM (2006)
Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis
H Dhillon et al.
NEURON (2006)
5-Hydroxytryptamine receptors in the human cardiovascular system
Alberto J. Kaumann et al.
PHARMACOLOGY & THERAPEUTICS (2006)
WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature
IB Lobov et al.
NATURE (2005)
SOST/sclerostin, an osteocyte-derived negative regulator of bone formation
RL Bezooijen et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Canonical Wnt/β-catenin signaling prevents osteoblasts from differentiating into chondrocytes
TP Hill et al.
DEVELOPMENTAL CELL (2005)
Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation
DA Glass et al.
DEVELOPMENTAL CELL (2005)
Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis
TF Day et al.
DEVELOPMENTAL CELL (2005)
WNT and β-catenin signalling:: Diseases and therapies
RT Moon et al.
NATURE REVIEWS GENETICS (2004)
Leptin receptor signaling in is required for normal body POW neurons weight homeostasis
N Balthasar et al.
NEURON (2004)
Genetic regulation of osteoclast development and function
SL Teitelbaum et al.
NATURE REVIEWS GENETICS (2003)
Synthesis of serotonin by a second tryptophan hydroxylase isoform
DJ Walther et al.
SCIENCE (2003)
A unique central tryptophan hydroxylase isoform
DJ Walther et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Leptin regulates bone formation via the sympathetic nervous system
S Takeda et al.
CELL (2002)
Leptin uptake by serotonergic neurones of the dorsal raphe
MC Fernández-Galaz et al.
JOURNAL OF NEUROENDOCRINOLOGY (2002)
High bone density due to a mutation in LDL-receptor-related protein 5
LM Boyden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor
M Kato et al.
JOURNAL OF CELL BIOLOGY (2002)
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development
YQ Gong et al.
CELL (2001)
Genetic control of skeletal development
EF Wagner et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2001)
Leptin receptor immunoreactivity is present in ascending serotonergic and catecholaminergic neurons of the rat
A Hay-Schmidt et al.
NEUROENDOCRINOLOGY (2001)
Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice
JA Gingrich et al.
PSYCHOPHARMACOLOGY (2001)
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein
ME Brunkow et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
LDL-receptor-related proteins in Wnt signal transduction
K Tamai et al.
NATURE (2000)
Intracerebroventricular infusion of leptin decreases serotonin transporter binding sites in the frontal cortex of the rat
Y Charnay et al.
NEUROSCIENCE LETTERS (2000)
Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass
P Ducy et al.
CELL (2000)
Therapeutic approaches to bone diseases
GA Rodan et al.
SCIENCE (2000)
Share Paper
